We are monitoring the impact of COVID-19 on North America Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 213
Share on
Share on

North America Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application & Country (The United States, Canada, Rest of the North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 213
Pages: 145

North America Antifungal Drugs Market Size (2020 to 2025)

As per the report published, the Antifungal Drugs Market size in North America is estimated at USD 4.97 billion in 2020. It is further projected to be growing at a CAGR of 3.7% and worth USD 5.96 billion by 2025. In the following years, the market is poised to grow significantly with the rising global population.

Antifungal drugs are commonly used to cure fungal infections due to unclean, unhygienic, and damp environments. Invasion of epithelial tissue by microscopic organisms leads to fungal infections. Systemic fungal infections are caused due to indigestion or inhalation of spores, leading to fungal pneumonia, and diseases like candidiasis, meningitis, mucormycosis, etc., are caused by opportunistic fungus. Although the majority of the fungal infections and diseases are commonly non-lethal, they are very uncomfortable to the host, and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as by inhibiting cell wall formation, cell membrane disruption, and cell division.

The major factors driving the market are rising awareness of fungal infections with more and more cases of antifungal infections worldwide, an increase in government and corporate funding in the industry. Further, the growing public-private partnership in the pharmaceutical industry and the mounting popularity of over-the-counter antifungal drugs to cure dermal infections are responsible for the growth of the North America antifungal drugs market. Also, the rising population with weak immune systems because of cancer chemotherapy or acquired immunodeficiency syndrome, in whom the fungal infections occur more frequently than average, is driving the market in North America. The existing high penetration of conventional drugs used to treat common fungal infections is restraining market growth.

High drug costs are a challenge faced by the market. Increasing treatment effectiveness can help in overcoming it.

This research report on the North American Antifungal Drugs Market has been segmented and sub-segmented into the following categories:

By Drug Type: 

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

By Therapeutic Indications: 

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Application: 

  • Powders
  • Ointments
  • Drugs
  • Pastes

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, North America has commanded the largest share of the global antifungal drugs market. The United States antifungal drugs market contributes to the major share of the North America antifungal drugs market due to the presence of the leading companies. Canada's antifungal drug market is expected to grow fastest in the North American region.

Some of the major companies dominating the North American Antifungal drugs market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead, and Abbott Laboratories.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 United States

                                6.3 Canada 

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. North America Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  2. North America Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Billion)
  3. North America Echinocandins Market, By Region, From 2020 to 2025 (USD Billion)
  4. North America Azoles Market, By Region, From 2020 to 2025 (USD Billion)
  5. North America Polyenes Market, By Region, From 2020 to 2025 (USD Billion)
  6. North America Allylamines Market, By Region, From 2020 to 2025 (USD Billion)
  7. North America Other Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  8. North America Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Billion)
  9. North America Aspergillosis Market, By Region, From 2020 to 2025 (USD Billion)
  10. North America Dermatophytosis Market, By Region, From 2020 to 2025 (USD Billion)
  11. North America Candidiasis Market, By Region, From 2020 to 2025 (USD Billion)
  12. North America Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Billion)
  13. North America Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Billion)
  14. North America Powders Market, By Region, From 2020 to 2025 (USD Billion)
  15. North America Ointments Market, By Region, From 2020 to 2025 (USD Billion)
  16. North America Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  17. North America Pastes Market, By Region, From 2020 to 2025 (USD Billion)
  18. United States Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Billion)
  19. United States Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Billion)
  20. United States Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Billion)
  21. Canada Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Billion)
  22. Canada Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Billion)
  23. Canada Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample